himachal pharmaceuticals
Tender Performance & Track Record
Company Overview
Tender Performance
Data for 01 April 2024 to 17 June 2025
Total Bids / Contract Value
Qualified Bids / Q Rate
Total Wins / Win Value
Wins Rate / Q-W Rate
Detailed Performance Analysis
Tender Performance by Ministries
Name
Top Bid Competitors
Companies that frequently compete with you in the same tenders — ranked by their total win value.You applied for 42 bids — NIJHON TECHNOLOGIES appeared in 11 of them.
HIMACHAL PHARMACEUTICALS
HIMACHAL PHARMACEUTICALS
Transform Your Tender Process
Join thousands of businesses winning more tenders
Smart Alerts
Get AI-powered tender recommendations
Market Intel
Track competitor bidding patterns
Email Reports
Weekly detailed analytics reports
Download Hub
Export tender data in bulk format
Smart Tracking
Never miss important deadlines
& Much More...
Discover all premium features with your trial
"TenderAI transformed our bidding process. We've increased our win rate by 40% and saved countless hours."
Historical Performance
7-year trend analysis (2018-2025)
Company Overview (1 Apr 2018-31 Mar 2025))
Total Bids
477
Contract Value
₹237.09 Cr
L1 Bids
128
Recent Win Rate
37.5%
Performance Analytics
HIMACHAL PHARMACEUTICALS: Business Analysis and Strategic Recommendations
HIMACHAL PHARMACEUTICALS demonstrates a strong presence in the government tender landscape. This comprehensive business analysis explores their financial performance, competitive positioning, and provides strategic recommendations to enhance their market share and profitability within the pharmaceutical industry.
Executive Summary:
HIMACHAL PHARMACEUTICALS exhibits a solid 26.8% win rate across 477 tender participations, securing 128 L1 bids. Their financial performance shows a substantial contract value secured, indicating effective targeting and conversion of public sector projects. Competitive analysis identifies key strengths and weaknesses, alongside opportunities for strategic growth.
Financial Performance of HIMACHAL PHARMACEUTICALS
This section analyzes the financial health and bidding performance of HIMACHAL PHARMACEUTICALS over the past several fiscal years.